[1] |
Zhang X, Li M, Chen S, et al. Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review[J]. Gastroenterology,2018, 155(2): 347-354.
|
[2] |
Allemani C, Matsuda T, Di Carlo V,et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37?513?025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet,2018, 391(10125): 1023-1075.
|
[3] |
中华人民共和国卫生部医政司. 胃癌诊疗规范(2011年版)[J/CD]. 中国医学前沿杂志(电子版), 2012, 4(5): 62-71.
|
[4] |
Hu Y, Huang C, Sun Y, et al. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial[J]. J Clin Oncol,2016, 34(12): 1350-1357.
|
[5] |
Hur H, Lee HY, Lee HJ, et al. Efficacy of laparoscopic subtotal gastrectomy with D2 lymphadenectomy for locally advanced gastric cancer: the protocol of the KLASS-02 multicenter randomized controlled clinical trial[J]. BMC Cancer,2015, 15: 355.
|
[6] |
Lee HJ, Hyung WJ, Yang HK, et al. Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT) [J]. Ann Surg,2019, 270(6): 983-991.
|
[7] |
Park YK, Yoon HM, Kim YW, et al. Laparoscopy-assisted versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: Results From a Randomized Phase II Multicenter Clinical Trial (COACT 1001) [J]. Ann Surg,2018, 267(4): 638-645.
|
[8] |
Inaki N, Etoh T, Ohyama T, et al. A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901) [J]. World J Surg,2015, 39(11): 2734-2741.
|
[9] |
Yu J, Huang C, Sun Y, et al. Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial[J]. JAMA,2019, 321(20): 1983-1992.
|
[10] |
Shakir F, Jan H, Kent A. 3D straight-stick laparoscopy versus 3D robotics for task performance in novice surgeons: a randomized crossover trial[J]. Surg Endosc,2016, 30(12): 5380-5387.
|
[11] |
Kanaji S, Suzuki S, Harada H, et al. Comparison of two- and three-dimensional display for performance of laparoscopic total gastrectomy for gastric cancer[J]. Langenbecks Arch Surg,2017, 402(3): 493-500.
|
[12] |
Lu J, Zheng CH, Zheng HL, et al. Randomized, controlled trial comparing clinical outcomes of sD and 2D laparoscopic surgery for gastric cancer: an interim report[J]. Surg Endosc, 2017, 31(7): 2939-2945.
|
[13] |
Chang JS, Kim KH, Yoon HI, et al. Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer[J]. Br J Surg,2017, 104(7): 877-884.
|
[14] |
Chang JS, Lim JS, Noh SH, et al. Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: implications for postoperative radiotherapy[J]. Radiother Oncol,2012, 104(3): 367-373.
|
[15] |
Kurokawa Y, Doki Y, Mizusawa J, et al. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial[J]. Lancet Gastroenterol Hepatol,2018, 3(7): 460-468.
|
[16] |
Nie RC, Yuan SQ, Chen S, et al. Bursectomy for advanced gastric cancer: an update meta-analysis[J]. World J Surg Oncol,2018, 16(1): 66.
|
[17] |
郑民华,洪希周. 3D腹腔镜胃癌根治术的发展与未来[J/CD]. 中华普外科手术学杂志(电子版), 2016, 10(1): 1-3.
|
[18] |
臧璐,马君俊,胡伟国,等. 3D腹腔镜胃癌手术的相关问题[J].中国普外基础与临床杂志,2016, 23(8): 908-909.
|
[19] |
王鹏鹏,张珂诚,陈凛. 3D微创外科技术在胃癌中的应用于选择[J/CD].中华普通外科学文献(电子版), 2018, 12(4): 217-219.
|
[20] |
胡建坤,赵林勇,陈心足. 3D腹腔镜胃癌根治术的应用前景[J].中国普外基础与临床杂志,2016, 23(8): 901-904.
|
[21] |
黄昌明,林建贤. 3D腹腔镜胃癌根治术的优势与技术[J/CD].中华普外手术学杂志(电子版), 2016, 10(1): 4-6.
|
[22] |
孙跃明. 3D与2D腹腔镜胃癌根治术的视觉评价[J]. 中华普外科手术学杂志(电子版), 2016, 10(1): 7-9.
|